A crystalline synthetic peptide representing the epitope of a monoclonal antibody raised against synthetic interferon-alpha 1 fragment 111-166

Eur J Biochem. 1985 Feb 1;146(3):689-91. doi: 10.1111/j.1432-1033.1985.tb08705.x.

Abstract

The antigenic determinant recognized by the monoclonal antibody that had been raised against synthetic human interferon-alpha 1 (IFN-alpha 1) fragment 111-166 [Arnheiter, H., Thomas, R.M., Leist, T., Fountoulakis, M., and Gutte, B. (1981) Nature (Lond.) 294, 278-280] and that cross-reacted with human IFN-alpha 1, IFN-alpha 2, and IFN-alpha A made in Escherichia coli, was localized to the region between residues 151 and 166 using synthetic COOH-terminal interferon fragments. In solid-phase radioimmunoassays neither the strongly hydrophilic COOH-terminal nonapeptide IFN 158-166 nor its mixtures with IFN 151-162 or IFN 149-158 showed any measurable interaction with the antigen binding site of the monoclonal antibody. For antibody binding, the full covalent structure of IFN 151-166 was required. Quantitatively very similar results were obtained with IFN 149-166 and IFN 143-166. The synthetic COOH-terminal hexadecapeptide of human IFN-alpha 1 (IFN 151-166) could be crystallized.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Chromatography, Affinity
  • Crystallization
  • Epitopes / analysis*
  • Humans
  • Interferon Type I* / chemical synthesis
  • Interferon Type I* / immunology
  • Interferon-alpha
  • Peptide Fragments / chemical synthesis
  • Peptide Fragments / immunology
  • Radioimmunoassay
  • Recombinant Proteins

Substances

  • Antibodies, Monoclonal
  • Epitopes
  • Interferon Type I
  • Interferon-alpha
  • Peptide Fragments
  • Recombinant Proteins
  • interferon, alpha 1(111-166)